Omeprazole magnesium
奥美拉唑镁
Report date: 2026/04/16 20:00:17
NME
Base Information
Drug NameOmeprazole magnesium
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[8]
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date1992/01/01
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A
Develop Information
Active CompaniesAstrazeneca Pharmaceutical Co LtdCheplapharm Arzneimittel GmbhAzurity Pharmaceuticals Inc +[6]
Inactive CompaniesNational Institute Of Diabetes And Digestive And Kidney Diseases
Active Indications +[7]
Inactive Indications